Live

Watch CBSN Live

First American dosed with Oxford-AstraZeneca phase three COVID-19 vaccine speaks out

Oxford University, in partnership with AstraZeneca, started testing the first U.S. volunteers as part of its phase three COVID-19 vaccine trial. CBS News chief medical correspondent Dr. Jon LaPook joins "CBS This Morning" with an exclusive interview with an American in the Oxford-AstraZeneca vaccine trial.
View CBS News In
CBS News App Open
Chrome Safari Continue